LSE - Delayed Quote GBp

Bioventix PLC (BVXP.L)

2,500.00
0.00
(0.00%)
At close: April 24 at 4:25:59 PM GMT+1

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
NameTitlePayExercisedYear Born
Mr. Peter John Harrison MA CEO & Director 387.78k -- 1958
Mr. Bruce Edward Heath Hiscock CFO & Director 97.33k -- 1958

Bioventix PLC

7 Romans Business Park
East Street
Farnham, GU9 7SX
United Kingdom
44 12 5272 8001 https://www.bioventix.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
17

Description

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. It also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Corporate Governance

Bioventix PLC’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

March 31, 2025 at 6:00 AM UTC

Bioventix PLC Earnings Date

Recent Events

April 10, 2025 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

GXE.BE Galapagos NV
23.04
+2.77%
 
4880.T CellSource Co., Ltd.
648.00
+0.62%
 
HVO.L hVIVO plc
16.35
-0.15%
 
FARN.L Faron Pharmaceuticals Oy
202.50
-3.57%
 
IBT.L International Biotechnology Trust plc
586.00
+1.03%
 
AVCT.L Avacta Group Plc
31.00
-6.06%
 
ONT.L Oxford Nanopore Technologies plc
122.10
+1.33%
 
GLPG.AS Galapagos NV
22.98
+2.32%
 
RIGL Rigel Pharmaceuticals, Inc.
19.06
+4.96%
 
GMAB.CO Genmab A/S
1,340.00
+0.75%